Emyria

D4, 661 Newcastle Street
Leederville WA 6007

Why Invest in Emyria?

Announcements

New investors

Corporate Governance

Annual Reports

Share Price

About Emyria

Home

Successes

Meet the Team

Contact Us

Updates

Montserrat

Emyria Limited

Emyria has opened its second Empax Centre within Perth Clinic, increasing treatment capacity by 50% to meet growing demand and payer requirements. 

The Centre is designed to deliver evidence-based mental health therapies within licensed healthcare environments and has already commenced our treatment programs for patients with PTSD and treatment-resistant depression with long-term follow-up data showing durable outcomes, supporting lasting patient impact. 

Emyria is now actively pursuing further expansion on the East Coast to address national demand and payer interest in innovative mental health care models. This expansion aligns with the company's goal to build a national network of Empax Centres supported by payers and focused on lasting impact. 

Investors can check out Emyria's interactive Investor Hub for the latest updates and announcements. Please note that forward-looking statements in this release are subject to change based on future events and developments.

Emyria has opened its second Empax Centre within Perth Clinic, increasing treatment capacity by 50% to meet growing demand and payer requirements. The Centre is designed to deliver evidence-based mental health therapies within licensed healthcare environments and has already commenced treatment for PTSD and treatment-resistant depression. Long-term follow-up data shows durable outcomes, supporting lasting patient impact. Emyria is actively expanding, with further Empax Centres planned for the East Coast to address national demand and payer interest in innovative mental health care models. This expansion aligns with the company's goal to build a national network of Empax Centres supported by payers and focused on lasting impact. Investors can reach out for more information or investment opportunities. Additionally, Emyria continues to develop new treatments and gather real-world data to enhance its therapy and drug development programs. Check out Emyria's interactive Investor Hub for the latest updates and announcements. Please note that forward-looking statements in this release are subject to change based on future events and developments.